Site to Site Transfer of Investigational Medicinal Product
Operating in a regulated industry, Boehringer Ingelheim had to follow strict, FDA-monitored procedures in many areas. Compliance training, such as this course covering site to site transfer of investigational medicinal products, must be completed successfully by company employees with associated job responsibilities.
The course teaches the involved individuals about the required processes, involved individuals, typical timelines, and other aspects for transferring investigational medicinal product from one site to another, in those instances where such transfer is necessary. The course covers the procedures and also the specific forms needed for FDA compliance.